Further results on the risk of nonfatal venous thromboembolism in users of the contraceptive transdermal patch compared to users of oral contraceptives containing …
S Jick, JA Kaye, L Li, H Jick - Contraception, 2007 - Elsevier
CONTEXT: In 2006, we published a study that indicated that the new transdermal
contraceptive patch containing ethinyl estradiol (EE) and the progestin norelgestromin did
not increase the risk for venous thromboembolism (VTE) compared to oral contraceptive
containing norgestimate and 35 μg of EE. OBJECTIVE: This report updates information on
the risk of nonfatal VTE in women using the contraceptive patch in comparison to women
using oral contraceptives containing norgestimate (either monophasic or triphasic) and 35 …
contraceptive patch containing ethinyl estradiol (EE) and the progestin norelgestromin did
not increase the risk for venous thromboembolism (VTE) compared to oral contraceptive
containing norgestimate and 35 μg of EE. OBJECTIVE: This report updates information on
the risk of nonfatal VTE in women using the contraceptive patch in comparison to women
using oral contraceptives containing norgestimate (either monophasic or triphasic) and 35 …